Abstract
• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis. • Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working. • Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.
| Original language | English |
|---|---|
| Pages (from-to) | 4386-4389 |
| Number of pages | 4 |
| Journal | European Radiology |
| Volume | 31 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2021 |
Bibliographical note
Publisher Copyright: © 2020, European Society of Radiology.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver